RaQualia Pharma Inc. Logo

RaQualia Pharma Inc.

4579 | T

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
Japan
Address:
名古屋市中村区名駅南一丁目21番19号
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

RaQualia Pharma Inc. is a Japanese biopharmaceutical company focused on the discovery, development, and commercialization of innovative drug candidates for various therapeutic areas. Established with a commitment to enhancing patient care, RaQualia harnesses advanced scientific research and cutting-edge technologies to address unmet medical needs. The company's portfolio includes a range of proprietary compounds aimed at treating conditions in areas such as pain management and gastrointestinal disorders. With a dedication to collaboration and strategic partnerships, RaQualia seeks to expedite the drug development process and bring effective therapies to market, contributing to the global healthcare landscape.

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for RaQualia Pharma Inc.. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-04-18 08:30
Regulatory News Service
臨時報告書
Japanese 21.1 KB
2025-03-31 09:01
Regulatory News Service
訂正有価証券届出書(参照方式)
Japanese 155.4 KB
2025-03-31 08:31
Regulatory News Service
訂正確認書
Japanese 8.2 KB
2025-03-31 08:30
Regulatory News Service
訂正有価証券報告書-第17期(2024/01/01-2024/12/31)
Japanese 811.9 KB
2025-03-26 08:05
Regulatory News Service
訂正有価証券届出書(参照方式)
Japanese 158.4 KB
2025-03-26 07:52
Regulatory News Service
臨時報告書
Japanese 22.7 KB
2025-03-26 07:51
Regulatory News Service
確認書
Japanese 8.2 KB
2025-03-26 07:50
Regulatory News Service
内部統制報告書-第17期(2024/01/01-2024/12/31)
Japanese 23.1 KB
2025-03-26 07:49
Annual Report
有価証券報告書-第17期(2024/01/01-2024/12/31)
Japanese 1.4 MB
2025-03-21 07:30
Prospectus
有価証券届出書(参照方式)
Japanese 282.6 KB
2024-12-13 08:00
Regulatory News Service
臨時報告書
Japanese 20.7 KB
2024-10-01 09:04
Regulatory News Service
訂正臨時報告書
Japanese 35.8 KB
2024-09-13 08:31
Regulatory News Service
臨時報告書
Japanese 37.9 KB
2024-08-14 08:47
Regulatory News Service
確認書
Japanese 8.2 KB
2024-08-14 08:46
Interim Report
半期報告書-第17期(2024/01/01-2024/12/31)
Japanese 234.4 KB

Automate Your Workflow. Get a real-time feed of all RaQualia Pharma Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for RaQualia Pharma Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
4BASEBIO PLC Logo
Manufactures GMP-compliant synthetic DNA for advanced therapies, vaccines, and cell/gene therapies.
United Kingdom 4BB
ABINGDON HEALTH PLC Logo
A CDMO for lateral flow rapid tests, providing end-to-end services and its own branded products.
United Kingdom ABDX
ABIONYX Pharma Logo
Biotech developing lipid-based therapies for rare renal and ophthalmological diseases.
France ABNX
AB Science Logo
Develops protein kinase inhibitors for oncology, neuro, and inflammatory diseases.
France AB
AcuCort AB Logo
Develops a rapid oral film for acute allergies, croup, and chemo-induced nausea.
Sweden ACUC
Advicenne Logo
Develops and commercializes therapies for rare renal diseases for patients of all ages.
France ALDVI
AegirBio AB Logo
Makes saliva-based diagnostics accessible for at-home & pro health & drug monitoring.
Sweden AEGIR
Aelis Farma Logo
Developing novel CB1 receptor inhibitors for treating brain and CNS disorders.
France AELIS
AGRONOMICS LIMITED Logo Isle of Man ANIC
ALK-Abelló Logo
Develops allergy immunotherapy (AIT) and emergency treatments for severe allergies.
Denmark ALK